When a drug is on shortage, those who compound may be able to prepare a version of the drug if certain federal requirements are met, says Amberly Johnson, PharmD, a clinical toxicologist and director of the Utah Poison Control Center

Daily targets: Sodium: 2,500-3,000mg with medical guidance Potassium: 4,700mg or more with medical monitoring Magnesium glycinate: 350mg supplemental (upper limit) Calcium citrate: 1,000-1,200mg supplemental (divided doses) Vitamin D: 2,000 IU daily Oral rehydration solution (ORS): As needed after each episode of fluid loss Implementation: Sip ORS continuously throughout the day Small frequent electrolyte doses rather than large single doses Bone broth as tolerated between meals Magnesium and calcium in divided doses to maximize absorption Daily symptom tracking including fluid intake, urine color, and episodes of vomiting or diarrhea Contact provider if unable to keep fluids down for more than 24 hours If you are on Protocol 3, talk to your healthcare provider about whether a dose adjustment is appropriate
Switching from tirzepatide to liraglutide Less common but sometimes necessary if tirzepatide causes intolerable side effects or if insurance changes affect coverage
Such monitoring may increase the risk of unnecessary procedures, due to the low test specificity for serum calcitonin and a high background incidence of thyroid disease
Meaningful appetite suppression typically begins at 5.0 mg, with significant weight loss acceleration happening at 10.0 mg and above